Learn more at LeadIQ.com

Insights

Gathering insights about Transcenta…

Similar companies to Transcenta

Transcenta Tech Stack

Transcenta uses 7 technology products and services including MATLAB, GSAP, jQuery, and more. Explore Transcenta's tech stack below.

MATLAB
Advanced Analytics And Data Science
GSAP
Javascript Frameworks
jQuery
Javascript Libraries
Swiper
Javascript Libraries
PHP
Programming Languages
Apache HTTP Server
Web Servers
Apache
Web Servers

Media & News

Transcenta Holding Limited is developing Claudin18.2 companion diagnostic to support Osemitamab.
Transcenta announces collaboration with Agilent to develop a Claudin18.2 companion diagnostic to support Osemitamab (TST001) global Phase III trial.
Apr 08, 2024 | au.investing.com
Transcenta Holding Limited partners with Agilent Technologies, Inc..
Transcenta has been collaborating with Agilent, a world leader in CDx development, to further develop this antibody for use in a companion diagnostic assay.
Apr 08, 2024 | au.investing.com
Transcenta Holding Limited launches lu-tst001 radionuclide antibody conjugate as potential novel treatment option for metastatic gastric cancer.
Transcenta announces the publication of preclinical results of [177lu]lu-tst001 radionuclide antibody conjugate as potential novel treatment option for metastatic gastric cancer in the European Journal of Nuclear Medicine and Molecular Imaging.
Dec 12, 2023 | www.biospace.com
Transcenta Holding Limited launched patient dosed in phase IIa study of claudin 18.2 monoclonal antibody TST001 on Feb 1st '22.
For instance, in February 2022, Transcenta Holding Limited, a clinical biopharmaceutical company, had announced the first patient dosed in phase IIa study of claudin 18.2 monoclonal antibody TST001 combined with cisplatin and gemcitabine for the first-line treatment of biliary tract cancer.
Jun 21, 2023 | www.digitaljournal.com
Transcenta Holding Limited is developing Osemitamab.
“Transcenta is committed to developing its best-in-class CLDN18.2 antibody, Osemitamab to the best of its potential.
Jan 18, 2023 | transcenta.com
Transcenta Holding Limited is developing TST004 for IgA nephropathy.
Transcenta discovered and developed TST004 in-house and plan to develop TST004 for IgA nephropathy (IgAN), a highly prevalent chronic kidney disease with very limited treatment options.
Oct 04, 2022 | transcenta.com
Merck partnered with Transcenta Holding Limited on Nov 7th '20.
Merck has announced a strategic technology collaboration with Transcenta, a global biotherapeutics company headquartered in China, to implement continuous manufacturing for protein therapeutics.
Nov 10, 2020 | www.biospectrumasia.com

Transcenta's Email Address Formats

Transcenta uses at least 1 format(s):

Transcenta Email Formats	Example	Percentage
First.Last@transcenta.com	John.Doe@transcenta.com	50%
First.Last@transcenta.com	John.Doe@transcenta.com	50%

Frequently Asked Questions

Where is Transcenta's headquarters located?

Transcenta's main headquarters is located at Princeton, US. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is Transcenta's official website and social media links?

Transcenta's official website is transcenta.com and has social profiles on LinkedIn.

How much revenue does Transcenta generate?

As of October 2024, Transcenta's annual revenue reached $35M.

What is Transcenta's SIC code NAICS code?

Transcenta's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Transcenta have currently?

As of October 2024, Transcenta has approximately 201 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Medical Officer: C. G.Head Of Translational Science Operation: A. L.Head Of Information Technology: R. L.. Explore Transcenta's employee directory with LeadIQ.

What industry does Transcenta belong to?

Transcenta operates in the Biotechnology Research industry.

What technology does Transcenta use?

Transcenta's tech stack includes MATLABGSAPjQuerySwiperPHPApache HTTP ServerApache.

What is Transcenta's email format?

Transcenta's email format typically follows the pattern of . Find more Transcenta email formats with LeadIQ.

Transcenta

Transcenta

Biotechnology ResearchPrinceton, United States201-500 Employees

Transcenta is a clinical stage biopharmaceutical company that fully integrates antibody-based biotherapeutics discovery, research, development and manufacturing. On September 29, 2021, Transcenta was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 06628.

Transcenta has established global footprint, with Headquarters and Discovery, Clinical and Translational Research Center in Suzhou, Process and Product Development Center and Manufacturing Facility in Hangzhou, and Clinical Development Centers in Beijing, Shanghai and Guangzhou in China and in Princeton, US, and External Partnering Center in Boston and Los Angeles, US. Transcenta is developing nine therapeutic antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. 

For more information, please visit www.transcenta.com.

Company Overview

Headquarters: Princeton, US
Website: transcenta.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 201-500

Media & News

Funding & Financials

$10M$50M
Transcenta's revenue is in the range of $10M$50M

Funding & Financials

$10M$50M
Transcenta's revenue is in the range of $10M$50M

Company Leadership

C. G.
Chief Medical Officer
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. L.
Head Of Translational Science Operation
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. L.
Head Of Information Technology
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. X.
Strategic Advisor To Ceo
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. L.
Partner
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

A. L.
Head Of Translational Science Operation
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. W.
Sr. Vp Biometrics And Data Sciences
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. S.
Vp Analytical Science And Process And Product Development Operation
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. L.
Sr. Vp Of Global Pharmacovigilance
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. L.
Head Of Information Technology
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Transcenta and Millions of Other Companies
Sign up for full access to Transcenta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.